4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-20-001885
Options or other derivatives
- Director acquired 24,274 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ros Matthew Director | 2020-01-02 | Grant or award · Stock Option (Right to Buy) | +24,274 | $0.45 | $11,001 | 24,274 | D |
Loading xslF345X03/doc4.xml…